Cite

HARVARD Citation

    Shah, A. et al. (2017). Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma. Arthritis & rheumatology. 69 (6), pp. 1306-1312. [Online]. 
  
Back to record